Marta Ferrer (M Ferrer)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Allergy

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Scientific reports

Human vaccines & immunotherapeutics

Clinica Universitaria de Navarra

Universidad de Navarra Facultad de Medicina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Clinica Universitaria de Navarra Aug 16 2007

Spain

Department Head :: Allergy

Education History

Universidad de Navarra Facultad de Medicina Oct 01 1979 - May 17 1995

Spain

PHD :: Allergy

Publications

Allen Phillip Kaplan, Marta Ferrer
An algorithm for the diagnosis, pathogenesis and treatment of chronic spontaneous urticaria, 2024 update. Allergy 79 (9) (2024)
L Zubiaga-Fernandez, A Testera-Montes, Carmen Rondón, N Perez-Sanchez, F Gomez-Perez, J M Vega-Chicote, J Bartra, Marta Ferrer, Ibon Eguiluz Gracia, M J Torres
Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2024)
Allen Phillip Kaplan, Marta Ferrer
Algorithms in allergy: Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy (2024)
Allen Phillip Kaplan, Marta Ferrer
An algorithm for the diagnosis, pathogenesis and treatment of chronic spontaneous urticaria, 2024 update. Allergy 79 (9) (2024)
L Zubiaga-Fernandez, A Testera-Montes, Carmen Rondón, N Perez-Sanchez, F Gomez-Perez, J M Vega-Chicote, J Bartra, Marta Ferrer, Ibon Eguiluz Gracia, M J Torres
Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticaria. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 54 (6) (2024)
Allen Phillip Kaplan, Marta Ferrer
An algorithm for the diagnosis, pathogenesis and treatment of chronic spontaneous urticaria, 2024 update Allergy (2024)
Karsten Weller, Gimenez-Arnau Ana Maria, Jens Baron, Randolf Brehler, Marta Ferrer, Adriane Groffik, Sonja Grundmann, Thilo Jakob, Moisés Labrador-Horrillo, Sabine Müller, Petra Staubach, Gerda Wurpts, Martin Metz, Marcus Maurer
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial. Allergy (2023)
María de la Paz Morales-Palacios, Jorge M Núñez-Córdoba, Eduardo Tejero, Óscar Matellanes, Paola Leonor Quan, Álvaro Carvallo, Sergio Sánchez-Fernández, Maite Urtasun, Carla Larrea, María Teresa Íñiguez, Rosa Giménez, Maria José Goikoetxea, Carmen M D'Amelio, Marta Ferrer, Gabriel Gastaminza
Reliability of a novel electro-medical device for wheal size measurement in allergy skin testing: An exploratory clinical trial. Allergy (2022)
Marta Ferrer, Nuria Rodriguez-Garijo, Marina Sabaté-Brescó
Medical algorithm: Diagnosis and management of histaminergic angioedema. Allergy (2022)
Eva Pescosolido, Yannick D Muller, Marina Sabaté-Brescó, Marta Ferrer, Daniel Yerly, Jean-Christoph Caubet, Jean-Pierre Lantin, Camillo Ribi, Marcel M Bergmann
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (11) (2022)
Torsten Zuberbier, Tamara Dörr, Werner Aberer, Montserrat Álvaro-Lozano, Elizabeth Angier, Stefania Arasi, Syed Hasan Arshad, Barbara Ballmer-Weber, Joan Bartra, Lisa A Beck, Philippe Bégin, Carsten Bindslev-Jensen, Jovanka Bislimovska, Jean Bousquet, Knut Brockow, Andrew Bush, Antonella Cianferoni, Michael J Cork, Adnan Custovic, Ulf Darsow, Nicolette de Jong, Diana Deleanu, Stefano R Del Giacco, Antoine Deschildre, Audrey Dunn Galvin, Motohiro Ebisawa, Montserrat Fernández-Rivas, Marta Ferrer, Alessandro Giovanni Fiocchi, Roy Gerth van Wijk, Maia Gotua, Kate Grimshaw, Josefine Grünhagen, Enrico Heffler, Michihiro Hide, Karin Hoffmann Sommergruber, Cristoforo Incorvaia, Christer Jansson, Swen Malte John, Carla Jones, Marek Jutel, Norito Katoh, Benjamin Kendziora, Tamar Kinaciyan, Edward Knol, Oksana Kurbacheva, Susanne Lau, Richard Loh, Carlo Lombardi, Mika Mäkelä, Mary Jane Marchisotto, Michael Makris, Marcus Maurer, Rosan W Meyer, Dragan Mijakoski, Jordan Minov, Joaquim Mullol, Caroline Nilsson, Anna Nowak-Wegrzyn, Bright Ibeabughichi Nwaru, Mikela Odemyr, Giovanni Battista Pajno, Sushil Paudel, Papadopoulos G Nikolaos, Harald Renz, Giampaolo Ricci, Johannes Ring, Barbara Rogala, Hugh A Sampson, Gianenrico Senna, Brigita Gradauskienė, Peter Kenneth Smith, Katarina Stevanovic, Sasho Stoleski, Hania Szajewska, Akio Tanaka, Ana Todo-Bom, Fatih Alexander Topal, Erkka Valovirta, Ronald van Ree, Carina Venter, Stefan Wöhrl, Gary Wing Kin Wong, Zuo-Tao Zhao, Margitta Worm
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper. Allergy (2021)
Cristobalina Mayorga, Ezequiel Pérez-Inestrosa, Javier Rojo, Marta Ferrer, María Isabel Montañez
Role of nanostructures in allergy: Diagnostics, treatments and safety. Allergy 76 (11) (2021)
Nicole Schoepke, Riccardo Asero, André Ellrich, Marta Ferrer, Ana Maria Giménez-Arnau, Clive E H Grattan, Thilo Jakob, George N Konstantinou, Ulrike Raap, Per Stahl Skov, Petra Staubach, Arno Kromminga, Ke Zhang, Carsten Bindslev-Jensen, Alvaro Daschner, Tamar Kinaciyan, Edward F Knol, Michael Makris, Nadine Marrouche, Peter Schmid-Grendlmeier, Gordon Sussman, Elias Toubi, Martin K Church, Marcus Maurer
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study. Allergy 74 (12) (2019)
Carlos Gamazo, Carmen D'Amelio, Gabriel Gastaminza, Marta Ferrer, Juan Manuel Irache
Adjuvants for allergy immunotherapeutics. Human vaccines & immunotherapeutics 13 (10) (2018)
Eva Serrano-Candelas, Rubén Martínez-Aranguren, Olga Vega, Gabriel Gastaminza, Joan Bartra, Maria Teresa Audicana, Jorge M Núñez-Córdoba, Jaime Algorta, Antonio Valero, Margarita Martin, Marta Ferrer
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells. Scientific reports 7 (1) (2017)

Marta Ferrer.css-eqlu8i{font-size:small;padding-left:4px;} (M Ferrer)

Publication Activity (10 Years)

Top Topics

Top Venues

Marta Ferrer (M Ferrer)